Angiotensin II antagonists - an assessment of their acute toxicity

ISSN： 1556-3650

Source： Clinical Toxicology, Vol.51, Iss.5, 2013-06, pp. : 429-434

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk-benefit assessment of angiotensin II receptor antagonists

By Shusterman Neil

Expert Opinion on Drug Safety, Vol. 1, Iss. 2, 2002-07 ,pp. : 137-152

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin II antagonists

By Smith R. Cunningham G. Kivlighn S.

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 81-94

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin II receptor antagonists -

By Burnier M. Brunner H.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 5, 1997-05 ,pp. : 489-500

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin II receptor antagonists challenge ACE inhibitors

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 252, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Comparative Safety and Tolerability of Angiotensin II Receptor Antagonists

By Mazzolai L. Burnier M.

Drug Safety, Vol. 21, Iss. 1, 1999-07 ,pp. : 23-33

Adis International

Access to resources Recommend Favorite